Cough Management Guidelines

Introduction to Cough Management

The European Respiratory Society recommends using dextromethorphan-based syrups for dry cough and guaifenesin-based syrups for wet/productive cough to help loosen and clear mucus 1, 2

The American Academy of Family Physicians suggests starting with simple home remedies like honey and lemon, which are often as effective as pharmacological treatments and represent the cheapest, simplest option 2, 3
Dextromethorphan is the preferred antitussive agent due to its superior safety profile compared to codeine or other opioid alternatives 2, 3
Maximum cough reflex suppression occurs at 60 mg of dextromethorphan, with effective dosing at 10-15 mg three to four times daily (maximum 120 mg/day) 3, 4
First-generation sedating antihistamines, like chlorpheniramine or promethazine, can suppress cough and are particularly useful for nocturnal cough due to sedative effects 2, 4

The European Respiratory Society states that cough suppression is not logical when patients are coughing up significant quantities of sputum, as the cough serves a physiological purpose to clear mucus from the bronchial tree 1
Guaifenesin is the standard expectorant used to loosen and relieve chest congestion in productive cough, although evidence for its benefit is limited 1
Avoid using expectorants, mucolytics, antihistamines, or bronchodilators for uncomplicated acute lower respiratory tract infections, as consistent evidence for beneficial effects is lacking 1

For dry, non-productive cough, consider antitussive therapy, and for wet, productive cough with sputum, avoid suppression and consider expectorant only if needed 1, 2

Using subtherapeutic doses of dextromethorphan, as standard OTC doses may be insufficient 2, 3
Suppressing productive cough with antitussives when secretion clearance is needed 1, 3
Prescribing codeine-based products, which offer no advantage over dextromethorphan but have worse side effects 2, 3
Continuing antitussive therapy beyond 3 weeks without full diagnostic workup for persistent cough 3
Missing serious underlying conditions, such as pneumonia, hemoptysis, or foreign body, before treating symptomatically 2

The American College of Physicians recommends that dextromethorphan should not be used in patients requiring assessment for pneumonia, characterized by symptoms such as rapid heart rate, rapid breathing, fever, or abnormal chest examination findings, as proper diagnosis and treatment of the underlying infection is necessary 5
For pneumonia with productive cough, treating the underlying pneumonia with appropriate antibiotics is the primary focus, rather than symptomatic cough suppression, as recommended by the European Respiratory Society 5

Dextromethorphan may be used for short-term symptomatic relief in acute bronchitis (not pneumonia) at doses of 30-60 mg, with maximum cough suppression occurring at 60 mg, according to the American College of Chest Physicians 5, 6